MUC1 and metastatic cancer: expression, function and therapeutic targeting.
about
Synthetic self-adjuvanting glycopeptide cancer vaccinesCXCR-4 Targeted, Short Wave Infrared (SWIR) Emitting Nanoprobes for Enhanced Deep Tissue Imaging and Micrometastatic Cancer Lesion Detection.Direct validation of aptamers as powerful tools to image solid tumorSerum Wisteria Floribunda Agglutinin-Positive Sialylated Mucin 1 as a Marker of Progenitor/Biliary Features in Hepatocellular Carcinoma.Lectin histochemistry reveals SNA as a prognostic carbohydrate-dependent probe for invasive ductal carcinoma of the breast: a clinicopathological and immunohistochemical auxiliary tool.Palmitoylation: a protein S-acylation with implications for breast cancer.Inhibition of KL-6/MUC1 glycosylation limits aggressive progression of pancreatic cancerDual-color labeled anti-mucin 1 antibody for imaging of ovarian cancer: A preliminary animal studyAnti-influenza neuraminidase inhibitor oseltamivir phosphate induces canine mammary cancer cell aggressiveness.Mucin1 shifts Smad3 signaling from the tumor-suppressive pSmad3C/p21(WAF1) pathway to the oncogenic pSmad3L/c-Myc pathway by activating JNK in human hepatocellular carcinoma cells.Combination of curcumin and bicalutamide enhanced the growth inhibition of androgen-independent prostate cancer cells through SAPK/JNK and MEK/ERK1/2-mediated targeting NF-κB/p65 and MUC1-C.Mucin1 expression in focal epidermal dysplasia of actinic keratosis.Significance of MUC1 expression in biopsy specimens of submucosal invasive gastric carcinoma: The association with lymph node metastasis.Expression Data Analysis for the Identification of Potential Biomarker of Pregnancy Associated Breast Cancer.CCL21-CCR7 promotes the lymph node metastasis of esophageal squamous cell carcinoma by up-regulating MUC1.Aberrant MUC1-TRIM46-KRTCAP2 Chimeric RNAs in High-Grade Serous Ovarian Carcinoma.Epigenetic silencing of miR-145-5p contributes to brain metastasisThe combined treatment with novel platinum(II) complex and anti-MUC1 increases apoptotic response in MDA-MB-231 breast cancer cells.Chemoresistance is associated with MUC1 and Lewis y antigen expression in ovarian epithelial cancers.Oncolytic vesicular stomatitis virus in an immunocompetent model of MUC1-positive or MUC1-null pancreatic ductal adenocarcinoma.Presentation of underglycosylated mucin 1 in pancreatic adenocarcinoma (PDAC) at early stages.MUC1 Is Expressed by Human Skin Fibroblasts and Plays a Role in Cell Adhesion and Migration.Targeting MUC1 and JNK by RNA interference and inhibitor inhibit the development of hepatocellular carcinoma.Mechanisms of antitumor and immune-enhancing activities of MUC1/sec, a secreted form of mucin-1.Role of integrin-linked kinase in regulating the protein stability of the MUC1-C oncoprotein in pancreatic cancer cells.Mucin-mediated nanocarrier disassembly for triggered uptake of oligonucleotides as a delivery strategy for the potential treatment of mucosal tumours.Mucin1 promotes the migration and invasion of hepatocellular carcinoma cells via JNK-mediated phosphorylation of Smad2 at the C-terminal and linker regions.Elucidation of epithelial-mesenchymal transition-related pathways in a triple-negative breast cancer cell line model by multi-omics interactome analysis.Anti-infective control in human bronchiolar epithelial cells by mucin phenotypic changes following uptake of N-acetyl-L-cysteine.Role of liver ICAM-1 in metastasis.Inverse association of rab31 and mucin-1 (CA15-3) antigen levels in estrogen receptor-positive (ER+) breast cancer tissues with clinicopathological parameters and patients' prognosis.Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium.A bulky glycocalyx fosters metastasis formation by promoting G1 cell cycle progression.Anti-MUC1 aptamer: A potential opportunity for cancer treatment.Conditional abrogation of transforming growth factor-β receptor 1 in PTEN-inactivated endometrium promotes endometrial cancer progression in mice.Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells.Mechanism of anticancer action of novel berenil complex of platinum(II) combined with anti-MUC1 in MCF-7 breast cancer cells.Inhibition of MUC1 biosynthesis via threonyl-tRNA synthetase suppresses pancreatic cancer cell migration.Immunization with a Synthetic Human MUC1 Glycopeptide Vaccine against Tumor-Associated MUC1 Breaks Tolerance in Human MUC1 Transgenic Mice.Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development.
P2860
Q26777837-2C7EBE22-BB8E-4A72-8B91-55E17B0CF495Q27330200-3CF56161-ADD6-446D-9DA0-7CFF608576D0Q33632641-839B46AE-3716-490C-8F03-F48911510C7AQ33670826-BC5F3058-E10F-486D-B011-C05F4413FD5CQ33802722-D8B6ABFE-E4E4-4219-83FB-AD80D9A597BDQ33915087-5D551EC3-E048-4464-9BD0-03E194100B8BQ34168525-4447CCFD-E91A-482E-B4E6-7D910F46DDCBQ35042084-E6A3D063-A710-44E0-9E81-F51F302E92A0Q35303234-CECCF264-BBA2-4953-8BE9-920D8D33521FQ35551987-821F4BE8-10AE-49C0-8E7A-219060DC7E90Q35658479-D1F3E3C8-3DEF-4A19-A826-36090DCD0EDFQ35852033-00B28013-6E38-45E3-9865-8DF80D292740Q35944506-C3B01597-B2AB-4C9D-94CE-2AFCFB9AED99Q36189018-FCDB8E13-99B5-4776-B285-6DFC1E146781Q36370199-722D5E6A-7478-4AA5-A2D9-D981B64D51E8Q36416107-21A649D6-5455-49BB-A5BE-C32E67977008Q36546293-2F0A7983-61FE-485E-BD0D-BE4996CAE51AQ36621615-03ABB8EB-DB1F-47B8-8B3D-A207D48AF031Q37007099-CBC0B0AA-D6E3-4C19-BA70-2CAF1A926BE8Q37123143-9E382A1C-FFC1-4221-AEA7-E1F4FC1A7814Q37298294-BED36DD4-C4D4-4B69-A5E5-F9CED482A933Q37715757-7724314F-8D7A-4B86-BE42-90F9975BC9E8Q37735660-A1D1AB48-85C9-444C-857F-3F632C6EF058Q38162151-C4BBB382-7867-42A0-81FD-DB6FBA819A7AQ38686618-6AAB3330-7938-46A5-B85A-5CF47A5C7B3CQ38809725-8FE19087-128F-4FC8-AF10-6B65E88071E2Q38865803-7C44D0B9-4B46-4CE1-AB7B-C9877F47874FQ38965929-2770934D-C71C-4B12-89A7-5FCD689F38C1Q41030022-8F6C9049-A7F3-45D7-950B-C938355AAF83Q41701847-2E0CA48F-2982-4CD3-99EB-590679FDDDD2Q41890324-B2AB48A6-C24F-4C08-811E-11379AD045E3Q47134733-1822E916-8663-41CE-BD27-95CE27E775DEQ47153817-14885508-8CD2-4DAB-BD11-164276282FA8Q48009199-2D46CF4F-9006-4F94-93BB-CA7D4313E58CQ48210146-C3C53496-A8FB-447C-9707-7E1AB1D3B69EQ48237710-CCDC6FA1-5429-4801-AF1F-A1069A5DBC86Q50053566-3A93589E-3C75-437F-8B4D-5DB6CFFAEAB7Q50069871-4C229FB8-979E-4814-9AE0-78B8DA54121DQ50908486-BD28C0B0-2C5E-42A7-BAF7-0F65AE85106CQ51653926-68CF9CD0-3DB2-403D-A4E0-9D229F49BCA9
P2860
MUC1 and metastatic cancer: expression, function and therapeutic targeting.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MUC1 and metastatic cancer: expression, function and therapeutic targeting.
@en
MUC1 and metastatic cancer: expression, function and therapeutic targeting.
@nl
type
label
MUC1 and metastatic cancer: expression, function and therapeutic targeting.
@en
MUC1 and metastatic cancer: expression, function and therapeutic targeting.
@nl
prefLabel
MUC1 and metastatic cancer: expression, function and therapeutic targeting.
@en
MUC1 and metastatic cancer: expression, function and therapeutic targeting.
@nl
P2860
P356
P1476
MUC1 and metastatic cancer: expression, function and therapeutic targeting.
@en
P2093
Joyce A Schroeder
Teresa M Horm
P2860
P304
P356
10.4161/CAM.23131
P577
2013-01-09T00:00:00Z